相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial
M. Christina Cox et al.
CLINICAL CANCER RESEARCH (2019)
Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
Nathan Suek et al.
FRONTIERS IN IMMUNOLOGY (2019)
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
Magnus Rizell et al.
FRONTIERS IN ONCOLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Vivek Subbiah et al.
CLINICAL CANCER RESEARCH (2018)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Janos L. Tanyi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability
Juan Lopez-Relano et al.
FRONTIERS IN IMMUNOLOGY (2018)
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank et al.
CANCER DISCOVERY (2018)
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming
Alfonso R. Sanchez-Paulete et al.
CANCER RESEARCH (2018)
In vivo cancer vaccination: Which dendritic cells to target and how?
Cheryl Lai-Lai Chiang et al.
CANCER TREATMENT REVIEWS (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Alexandra-Chloe Villani et al.
SCIENCE (2017)
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
Abhishek D. Garg et al.
TRENDS IN IMMUNOLOGY (2017)
Trial watch: Dendritic cell-based anticancer immunotherapy
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
Anna Laurell et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Therapeutic antibodies against cancer stem cells: a promising approach
Smarakan Sneha et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
L. M. A. Aparicio et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Jay M. Lee et al.
CLINICAL CANCER RESEARCH (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Tumor-derived factors modulating dendritic cell function
Jinbao Zong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
Sumita Trivedi et al.
CLINICAL CANCER RESEARCH (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
Caterina Lapenta et al.
JOURNAL OF IMMUNOLOGY (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
Carmela Rozera et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
Arne Kolstad et al.
BLOOD (2015)
Natural Killer Cells: The Secret Weapon in Dendritic Cell Vaccination Strategies
Catharina H. M. J. Van Elssen et al.
CLINICAL CANCER RESEARCH (2014)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Tumoricidal activity of human dendritic cells
Jurjen Tel et al.
TRENDS IN IMMUNOLOGY (2014)
Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
Raghvendra M. Srivastava et al.
CLINICAL CANCER RESEARCH (2013)
Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
Lisa H. Butterfield
FRONTIERS IN IMMUNOLOGY (2013)
Immunogenic cell death in radiation therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2013)
IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing
Francesca Spadaro et al.
BLOOD (2012)
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Youn H. Kim et al.
BLOOD (2012)
Regulatory dendritic cells in the tumor immunoenvironment
Galina V. Shurin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines
Chun Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy
Steven Eric Finkelstein et al.
IMMUNOTHERAPY (2012)
COMBINATION OF EXTERNAL BEAM RADIOTHERAPY (EBRT) WITH INTRATUMORAL INJECTION OF DENDRITIC CELLS AS NEO-ADJUVANT TREATMENT OF HIGH-RISK SOFT TISSUE SARCOMA PATIENTS
Steven E. Finkelstein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients
Hisahito Endo et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
Shinichi Fujiwara et al.
JOURNAL OF IMMUNOTHERAPY (2012)
A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer
Gary K. Koski et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Monocyte-derived DC maturation strategies and related pathways: a transcriptional view
Luciano Castiello et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12
Stefano M. Santini et al.
PLOS ONE (2011)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors
Joshua D. Brody et al.
BLOOD (2009)
Dendritic cell-based therapeutic cancer vaccines: what we have and what we need
Pawel Kalinski et al.
FUTURE ONCOLOGY (2009)
Dendritic Cell Maturation With Poly(I:C)-based Versus PGE2-based Cytokine Combinations Results in Differential Functional Characteristics Relevant to Clinical Application
Ines Möller et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice
Chengwen Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy
Seagal Teitz-Tennenbaum et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Dendritic cells: Understanding immunogenicity
Ralph M. Steinman
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M. Obeid et al.
CELL DEATH AND DIFFERENTIATION (2007)
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
Jun Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and bacillus Calmette-Guerin cell wall skeleton stimulation
Masaru Udagawa et al.
CLINICAL CANCER RESEARCH (2006)
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
Jinwei Hu et al.
CANCER RESEARCH (2006)
Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells
M Vera et al.
MOLECULAR THERAPY (2005)
Natural killer-dendritic cell cross-talk in cancer immunotherapy
P Kalinski et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8
E Feijoó et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
R Yamanaka et al.
CLINICAL CANCER RESEARCH (2005)
Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma
KW Chi et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas
G Mazzolini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity
SC Yang et al.
CLINICAL CANCER RESEARCH (2004)
Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
K Furumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
MIP-3α transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity
B Bonnotte et al.
JOURNAL OF IMMUNOLOGY (2004)
Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-α
C Lapenta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Monocyte-derived dendritic cells generated after a short-term culture with IFN-α and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response
L Santodonato et al.
JOURNAL OF IMMUNOLOGY (2003)
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
G Ferlazzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Reciprocal activating interaction between natural killer cells and dendritic cells
F Gerosa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells
SX Liu et al.
JOURNAL OF IMMUNOLOGY (2001)
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
SM Santini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication
PW Miller et al.
HUMAN GENE THERAPY (2000)
分享论文
